Millipore Sigma Vibrant Logo

230950 Ciglitazone - CAS 74772-77-3 - Calbiochem

View Products on Sigmaaldrich.com
230950
가격 및 재고 조회

개요

Replacement Information

주요 사양표

CAS #Empirical Formula
74772-77-3C₁₈H₂₃NO₃S

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
230950-5MGCN
재고 정보 검색...
현재 재고 없음
현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      Plastic ampoule 5 mg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      가격 문의
      Description
      OverviewA potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective PPARγ agonist (EC50 = 3 µM).
      Catalogue Number230950
      Brand Family Calbiochem®
      Synonyms(±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione, PPAR Agonist II, PPARγ Agonist I
      References
      ReferencesJha, R.J. 1999. Clin. Exp. Hypertens. 21, 157.
      Xin, X., et al. 1999. J. Biol. Chem. 274, 9116.
      Lohrke, B., et al. 1998. J. Endocrinol. 159, 429.
      Willson, T.M., et al. 1996. J. Med. Chem. 39, 665.
      Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977.
      Product Information
      CAS number74772-77-3
      ATP CompetitiveN
      FormWhite to tan solid
      Hill FormulaC₁₈H₂₃NO₃S
      Chemical formulaC₁₈H₂₃NO₃S
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetSelective PPARγ agonist
      Primary Target IC<sub>50</sub>EC50 = 3 µM as PPARγ agonist
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSXJ5813700
      Safety Information
      R PhraseR: 20/21/22

      Harmful by inhalation, in contact with skin and if swallowed.
      S PhraseS: 36

      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsStock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      230950-5MGCN 04055977218312

      Documentation

      Ciglitazone - CAS 74772-77-3 - Calbiochem MSDS

      타이틀

      물질안전보건자료(MSDS) 

      Ciglitazone - CAS 74772-77-3 - Calbiochem Certificates of Analysis

      TitleLot Number
      230950

      References

      참고문헌 보기
      Jha, R.J. 1999. Clin. Exp. Hypertens. 21, 157.
      Xin, X., et al. 1999. J. Biol. Chem. 274, 9116.
      Lohrke, B., et al. 1998. J. Endocrinol. 159, 429.
      Willson, T.M., et al. 1996. J. Med. Chem. 39, 665.
      Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-January-2020 JSW
      Synonyms(±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione, PPAR Agonist II, PPARγ Agonist I
      DescriptionA potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective peroxisome proliferator-activated receptor γ (PPARγ) agonist (EC50 = 3 µM).
      FormWhite to tan solid
      CAS number74772-77-3
      RTECSXJ5813700
      Chemical formulaC₁₈H₂₃NO₃S
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (≥ 25 mg/ml) or Ethanol (≥25 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsStock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful
      ReferencesJha, R.J. 1999. Clin. Exp. Hypertens. 21, 157.
      Xin, X., et al. 1999. J. Biol. Chem. 274, 9116.
      Lohrke, B., et al. 1998. J. Endocrinol. 159, 429.
      Willson, T.M., et al. 1996. J. Med. Chem. 39, 665.
      Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977.